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Abstract
Background: Early pregnancy loss (EPL) is a frustrating clinical problem, whose mechanisms are not completely
understood. DNA methylation, which includes maintenance methylation and de novo methylation directed by DNA
methyltransferases (DNMTs), is important for embryo development. Abnormal function of these DNMTs may have
serious consequences for embryonic development.
Methods: To evaluate the possible involvement of DNA methylation in human EPL, the expression of DNMT
proteins and global methylation of DNA were assessed in villous or decidua from EPL patients. The association of
maintenance methylation with embryo implantation and development was also examined.
Results: We found that DNMT1 and DNMT3A were both expressed in normal human villous and decidua. DNMT1
expression and DNA global methylation levels were significantly down-regulated in villous of EPL. DNMT3A
expression was not significantly changed in the EPL group compared to controls in either villous or decidua. We
also found that disturbance of maintenance methylation with a DNMT1 inhibitor may result in a decreased global
DNA methylation level and impaired embryonic development in the mouse model, and inhibit in vitro embryo
attachment to endometrial cells.
Conclusions: Our results demonstrate that defects in DNA maintenance methylation in the embryo, not in the
mother, are associated with abnormal embryonic implantation and development. The findings of the current study
provide new insights into the etiology of EPL.
Background
Early pregnancy loss (EPL) is one of the most common
reproductive failures of human pregnancy. It is character-
ized as high incidence, but the etiology is ambiguous. At
least 75% of women experience one or more EPL, which
includes loss of unrecognized or histologically recognized
pregnancies. The incidence of recognized EPL is approxi-
mately 10% to 15% [1]. Although there are various possible
etiological factors associated with EPL, such as embryonic
chromosomal abnormality, maternal endocrine diseases,
anatomical abnormalities of the reproductive system,
environmental influences and immunologic factors, the
molecular mechanisms of EPL remain incompletely
described [2-4].
In mammals, the global DNA epigenetic profile of the
genome is dynamically reprogrammed during embryogen-
esis and the early development of the fetus [5]. These
dynamic processes are vital for the fertilization and histolo-
gical differentiation of the embryo [6]. DNA methylation,
as the primary regulator of hereditary information, occurs
exclusively at CpG dinucleotides [7]. These CpG islands
are often among the promoter regions of genes and methy-
lation of CpG islands results in transcriptional repression
However, aberrant DNA methylation has been found to
lead to abnormal embryonic development, birth malforma-
tions and other diseases, such as human carcinoma [8,9].
De novo methylation and maintenance methylation are
distinct processes that are required for the establishment
and inheritance of tissue-specific methylation patterns,
especially during implantation. Three main DNA
methyltransferase enzymes (DNMT) including DNMT1,
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DNMT3A and DNMT3B have been characterized [10].
DNMT1, with its high affinity for hemimethylated DNA
in vitro, predominantly catalyzes maintenance methyla-
tion via binding to proliferating cell nuclear antigen in
replication foci during S phase [11]. DNMT3A and
DNMT3B are mainly responsible for de novo methyla-
tion that establishes a new DNA methylation state at
repeat sequences, imprinted genes, and developmental
genes [12,13].
The establishment of appropriate methylation patterns
depends on a methodical regulation of the methyltransfer-
ase activity. Dysfunction of any of these DNMTs may have
serious consequences for embryonic development and
subsequent gestation, even embryonic lethality, as the
epigenetic status of genes or repeat sequences have a pro-
found effect on cell physiology and can markedly alter
embryonic and fetal development [12,14-16]. It was
reported that DNMT1-/- mice embryos have genome-wide
demethylation and developmental arrest at the early stage
of gestation [17]. DNMT3a-/- or DNMT3b-/- mice failed to
initiate de novo methylation after implantation and also
exhibited embryonic development arrest [14,18]. Ineffi-
cient epigenetic reprogramming caused by abnormal
expression of DNMTs may be closely associated with a
high rate of abortion and developmental abnormalities in
bovine clones [19]. However, it remains unclear whether
dysfunction of DNMTs is involved in human early preg-
nancy loss.
To evaluate the role of DNA methylation in the patho-
genesis of early pregnancy loss, we detected the expression
of DNMTs protein and global DNA methylation state in
human EPL and found that insufficient maintenance
methylation existed in the villi of EPL. Further, we found
that inhibition of DNMT1 impaired embryo implantation
and embryonic development capacity in vivo. The findings
of the current study indicated that defects in maintenance
methylation in the embryo were associated with abnormal
embryonic implantation and development.
Methods
Human subjects and sample collection
Villous and decidual tissues were collected from patients
with EPL and women undergoing selective pregnancy ter-
mination in the first-trimester (gestational age, seven to
nine weeks) for nonmedical reasons in Women’s Hospital,
School of Medicine, Zhejiang University, between Septem-
ber 2006 and May 2007. Tissues were snap-frozen in
liquid nitrogen and stored at -80°C until assay by Western
blot analysis or fixed in paraformaldehyde (PFA) for
immunohistochemistry. EPL was diagnosed based on the
presence of vaginal bleeding and/or lower abdominal pain,
together with the findings of pelvic and ultrasonic exami-
nation. Exclusion criteria included chromosomal abnorm-
alities, endocrine diseases, infections and anatomical
abnormalities of the genital tract, immunological diseases,
trauma, signs of other concurrent medical complications
and any chemical agent intake before sample collection
[20]. Written informed consents were obtained from all
patients who provided samples and the protocol was
approved by the Ethical Review Committee of Women’s
Hospital, School of Medicine, Zhejiang University.
Collection of mouse embryos and tissues
Animal care followed the guidelines recommended by the
Animal Care and Use Committee (ACUC) of the School
of Medicine, Zhejiang University. Female ICR mice (six to
seven weeks old) were synchronized and superovulated by
intraperitoneal injection of 7.5 IU pregnant mare serum
gonadotropin (PMSG) and human chorionic gonadotropin
(hCG, Organon, Oss, The Netherlands). Thirty mice were
bred with proven breeder males and were checked the
next day for a copulation plug (designated as Day 0 of
gestation). Twenty pregnant mice were sacrificed on day 4
to collect blastulas by flushing the uterus with modified
human tubal fluid (MHTF; Irvine Scientific, Irvine, CA,
USA) as described previously [21]. The pregnant mice
were anesthetized by 10% chloral hydrate (0.4 ml/100 g,
Sinopharm Chemical Reagent, Beijing, China) on the fifth
day of gestation (around implantation time) and then sub-
jected to operation on the loin to expose the uterine
horns. Five microliters of procainamide (1 mM) (Sigma,
St. Louis, MO, USA) was injected slowly into the left side
uterine cavity using a 30-gauge needle and 5 μl sterile sal-
ine (vehicle) was injected into the right side as control.
The incision was then closed and the mice were sacrificed
on day 11 to observe the number of embryos implanted
and embryonic development. Mouse embryos were
collected and stored at -80°C for assay of global DNA
methylation. Uteri were collected and then either fixed in
PFA for immunohistochemistry analysis or Haematoxylin
& Eosin (H&E) staining.
Cell culture and embryo attachment test
Ishikawa cells were cultured in Ham F-12/(D)MEM
(1:1) containing 30% fetal calf serum, progesterone
(63.5 nmol/L), estradiol-17b (7.14 nmol/L), insulin
(100 mg/ml) and epidermal growth factor (20 ng/ml)
in a humidified condition composed of 20% oxygen
and 5% carbon dioxide at 37°C.
Embryos (n = 142) obtained via flushing mouse uteri
were rinsed three times in MHTF and cultured in the pre-
sence or absence of procainamide (0.5 mM), a DNMT1
inhibitor, for 24 hours. The embryos were then transferred
to a dish covered with a single layer of Ishikawa cells that
mimics endometrial cells as described previously [22]. The
number of implanted embryos was counted at 48 hours
and 72 hours of culture. The presence of blastocyst adher-
ence to the dish bottom and the erosion of Ishikawa cells
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by the blastocyst invasion were considered successful
embryo implantation.
Western blotting analysis
Samples of 150 mg villous or decidual tissues were homo-
genized in 500 μl of ice-cold lysis buffer containing
50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.02% sodium
azide, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycho-
late, 100 μg/ml phenylmethyl-sulfonyl fluoride (PMSF)
(Sigma), and 100 μg/ml leupeptin (Sigma). The superna-
tant was collected after centrifugation at 15,000 g for
20 minutes at 4°C and protein concentrations were deter-
mined using the Bradford method (Bio-Rad Laboratories,
Hercules, CA, USA).
Western blot analysis of DNMT1 and DNMT3A was
performed as previously described [19]. Briefly, the pro-
teins (60 μg) were separated on SDS-PAGE and probed
by anti-DNMT1 (Novus Biologicals, Littleton, CO, USA)
or anti-DNMT3A (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) and anti-b-actin antibody (Santa Cruz
Biotechnology) overnight at 4°C. Then the membranes
were incubated with second antibody for 1 hour at
room temperature after thorough washing with buffer.
The signal was visualized with ECL kits according to the
manufacturer’s instructions (Amersham Biosciences, Lit-
tle Chalfont, Buckinghamshire, UK) and exposed to film.
The density of immunoblotting was quantified with the
software Quantity One (Bio-Rad Laboratories, Hercules,
CA, USA). The expression of target proteins was nor-
malized against internal control b-actin.
Immunohistochemistry and immunocytochemistry
analysis
Tissues fixed in PFA were dehydrated and embedded in
paraffin. Sections of 4 micrometers were cut and mounted
onto slides. After deparaffinization, rehydration and block-
ade, sections were rinsed three times with washing buffer,
incubated with primary antibody (rabbit anti-DNMT1
(Novus Biologicals, Littleton, CO, USA)) and rabbit anti-
DNMT 3A (Santa Cruz Biotechnology) for 1 hour at room
temperature. After rinsing three times with washing buffer,
the sections were incubated with horseradish peroxidase
conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology)
for 30 minutes. The signals were visualized with DAB+
Substrate Chromogen solution (DAKO, Tokyo, Japan) and
observed under Eclipse E400 microscopy (Nikon, Tokyo,
Japan).
To detect the expression of leukemia inhibitory factor
(LIF) in Ishikawa cells, cells were mounted to coverslips,
fixed with PFA and permeated with Triton X-100. Rabbit
anti-LIF antibody (1:50 dilution, Santa Cruz Biotechnol-
ogy) was used as the primary antibody for the detection of
LIF. The signal was visualized as described above.
Global methylation of DNA in human villous and mouse
embryo
Genomic DNA was extracted from human villous of the
EPL group and the normal pregnant group and mouse
embryos at day 11 with a commercially available kit (Axy-
gen, Union City, CA, USA). The level of global DNA
methylation was determined by the Methylamp Global
DNA Methylation Quantification Ultra Kit (Epigentek,
Farmingdale, NY, USA). In this assay, 5-methylcytosine-
modified genomic DNA is recognized by 5-methylcytosine
antibody and the bound DNA is quantified in a colori-
metric reaction. Positive (methylated) and negative
(unmethylated) control DNA was supplied with the kit.
The proportion of methylated nucleotides in the total
genomic DNA was shown (methylation %). For sample
calculation of DNA methylation, the following formula
was used: Methylation % = (Sample OD-Negative Control
OD)/X*/(Positive Control OD-Negative Control OD) ×
10 × 100% (* × is the GC content of the species DNA (GC
content is 41% for human genomic DNA, 42% for mouse).





The expression of DNMT1 and DNMT3A and the level
of global DNA methylation are presented in means ±
SEM and compared with the Mann-Whitney test. Chi-
square test was used to compare the rate of in vitro
embryonic implantation and the paired t-test was used
to test the in vivo effect of DNMT1 inhibition on
embryo implantation. Animal experiments were repli-
cated at least three times. P <0.05 was considered statis-
tically significant. Statistical analysis was performed
using the SPSS 16.0.
Results
Decreased DNMT1 expression level in human villous of
EPL
Western blot analysis revealed that the DNMT1 expres-
sion level was significantly lower in villous of women
with an EPL (n = 16) than controls (n = 16) (P = 0.023,
Figure 1A), but there was no significant difference in
DNMT1 expression in the decidua (P = 0.815, Figure
1A). There were no significant differences in the expres-
sion level of DNMT3A in either villous or decidua
between EPL (n = 16) and control (n = 16) specimens
(P = 0.294 and P = 0.194, respectively, Figure 1B).
Immunohistochemistry analysis showed the localization
of both DNMT1 and DNMT3A in the nucleus of tro-
phoblast and the nucleus of the glandular epithelium of
decidua (Figure 2).
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Reduced DNA methylation level in villous of EPL
The levels of global DNA methylation in the villous of
women with EPL (n = 16) and normal pregnant women
(n = 16) are shown in Figure 3. The global DNA methyla-
tion was significantly reduced in villous from women
with EPL compared to controls (P = 0.0164). It was
noticed that these assays are influenced strongly by
mCpG density, such that regions that are more highly
methylated are detected with much greater ease than
regions of low methylation density. Thus, we did not
observe the absolute level of DNA methylation, but
showed a difference between the groups being compared.
Inhibition of DNMT1 activity impaired in vivo embryo
implantation and development
Fifty percent (n = 10) of mice injected with procainamide,
an inhibitor of DNMT1, in the uterus presented with
vaginal bleeding but recovered before Day 11 of gesta-
tion. On Day 11, the number of embryos implanted in
the uterine horn injected with procainamide was signifi-
cantly reduced compared with controls (n = 10), P < 0.05
(Figure 4A and 4B). The global DNA methylation level of
embryos obtained from the procainamide-injected horn
was significantly lower than that of controls (P = 0.0155,
Figure 4C). The mouse embryos and placentas obtained
Figure 1 Alterations of expression levels of DNMT1 and DNMT3A in human villous and deciduas detected by western blot. A: The
expression level of DNMT1 in villous was significantly lower in the EPL group than in the control. There was no difference in the DNMT1
expression level in the decidua between the two groups. B: The expression level of DNMT3A was not significantly different in either the villous
or decidua between the EPL and control groups. The data are shown as means ± SEM. EPL group: n = 16; control group: n = 16. * P < 0.05. EPL,
early pregnancy loss; SEM, standard error of the mean.
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from the control horn appeared to be normal, but those
from the procainamide-injected horn were abnormally
developed (Figure 5A). H & E staining of the mouse
uterus of non-implantation sites revealed a similar struc-
ture between procainamide-injected horns and control
horns (Figure 5B).
Blockade of DNMT1 activity inhibited embryo attachment
to endometrial cells
The number of embryos attached to Ishikawa cells was
30/71 (42%) and 55/71 (77%) at 48 hours and 72 hours,
respectively. The inhibition of DNMT1 with procaina-
mide significantly decreased the embryo attachment rate
Figure 2 Immunohistological detection of DNMT1 and DNMT3A in human villous and decidua. A: The staining of DNMT1 and DNMT3A
were both localized in the nucleus of villous trophoblasts. B: The staining of both DNMT1 and DNMT3A was localized in the nucleus of the
glandular epithelium of decidua (The bar represents 50 μm).
Yin et al. BMC Medicine 2012, 10:26
http://www.biomedcentral.com/1741-7015/10/26
Page 5 of 10
to 18/71 (25%) and 43/71 (61%) at 48 hours and 72
hours, respectively (P = 0.033 for 48 hours; P = 0.029
for 72 hours) (Figure 6). We found that inhibition of
DNMT1 activity did not significantly affect the expres-
sion of LIF, a marker of endometrial receptivity, in Ishi-
kawa cells (Figure 6).
Discussion
During mammalian embryo implantation and develop-
ment, DNA methylation undergoes dramatic reprogram-
ming that is crucial for the development of both the
embryo and the maternal endometrium [23-26]. In the
present study, we showed that DNMT1 and DNMT3A
were expressed in human villous trophoblast and glandu-
lar epithelial cells of decidua. DNMT1 was significantly
down-regulated in the villous of women with EPL, but
not in the decidua. DNMT3A expression was not signifi-
cantly changed in the EPL group compared to the control
group. The global DNA methylation level was signifi-
cantly lower in the EPL villous than in villous from the
controls. These findings suggest that insufficient embryo-
nic maintenance methylation is associated with abnormal
embryonic development in human early pregnancy loss.
Evidence from in vitro and in vivo studies confirmed the
importance of maintenance DNA methylation in embryo
implantation and development. To the best of our knowl-
edge, this is the first report describing defects in DNA
maintenance methylation in the pathogenesis of EPL.
In the present study, we first demonstrated that DNMT1
and DNMT3A proteins were expressed in the nuclei of
the villous trophoblast and glandular epithelium of normal
human decidua. DNMT3B, a de novo methyltransferase,
was detected with low expression in decidual tissue, but
not in villous (data not shown). The most likely explana-
tion is that DNMT3B is not expressed in extra-embryonic
lineages of post-implantation embryos [27]. The expres-
sion of both DNA methyltransferases suggests that
DNMT1 and DNMT3A may be DNA methylation regula-
tory enzymes at the feto-maternal interface during early
embryo development. Subsequent semiquantitative analy-
sis supported a pathological role of DNMT1 in EPL.
De novo methyltransferase DNMT3A expression had no
evident relationship with EPL. A possible reason might be
that de novo methylation mainly happens during epige-
netic reprogramming in the gametes and preimplantation
embryo [28,29]. After embryo implantation, the methyla-
tion is maintained by DNMT1 [30] and there is no
Figure 3 Alterations of global DNA methylation level in villous.
The global DNA methylation level was significantly down-regulated
in human villous of the EPL group compared to the control group.
The data are shown as means ± SEM. EPL group: n = 16; control
group: n = 16. * P < 0.05. EPL, early pregnancy loss; SEM, standard
error of the mean.
Figure 4 The effect of DNMT1 inhibition on embryo implantation
and DNA methylation level in vivo. A: The fetal number was
significantly less in the uterine horn injected with DNMT1 inhibitor
than in the control horn. The data are shown as means ± SEM.
Procainamide group: n = 10; control group: n = 10. * P < 0.05. B: The
global DNA methylation level was significantly lower in mouse
embryos obtained from the uterine horn injected with DNMT1
inhibitor than in those from the control horn. The data are shown as
means ± SEM. Procainamide group: n = 18; control group: n = 18.
* P < 0.05. SEM, standard error of the mean.
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noticeable de novo methylation change in the post-differ-
entiated human villous [31].
For the global methylation assay, we used the Methy-
lamp™ Global DNA Methylation Quantification Ultra Kit.
This commercial product for global methylation assay is
commonly used [32]. The assay uses a 5-methylcytosine
antibody to distinguish methylated from unmethylated
cytosine. These assays are influenced significantly by
mCpG density so that more highly methylated regions are
detected better than regions of low methylation density.
These methods do not offer accurate quantitative results;
however, they do allow comparisons between groups. The
methylation levels in the EPL group and the control group
were measured at the same time with the same kit to
decide whether there is a relative difference of DNA
methylation level between the two groups. Our results
show that, compared with the control group, global DNA
methylation was significantly reduced in the EPL group
both in the patient samples and in the animal model.
The alterations in the expression of DNMT1 and global
demethylation in villous of the EPL women suggest that
aberrant maintenance DNA methylation may be involved
in the pathogenesis of human EPL. It was reported that
mouse embryos lacking Dnmt1 showed genome-wide
demethylation and knockout of Dnmt1 in embryos led to
a complete loss of methylation at both paternally and
maternally methylated differential methylation regions
(DMRs) [17]. Mice deficient in the maintenance of geno-
mic imprints exhibited significant developmental delays
in multiple organ systems [33]. Since demethylation of
Figure 5 The effects of DNMT1 inhibition on embryonic and placental development. A: The embryos and placenta developed normally in
the control horn but the embryos and placenta in the uterine horn injected with a DNMT1 inhibitor showed growth retardation (The bar
represents 1.5 mm). B: H & E staining showed that there was no obvious structural difference in the endometrial tissue of the non-implantation
site between the two sides of uterine horn with or without DNMT1 inhibitor injection (The bar represents 200 μm). H & E, hematoxylin and
eosin.
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Figure 6 The effect of DNMT1 inhibition on embryonic attachment in vitro. A: Blastulas collected from ICR mice were pre-treated with or
without DNMT1 inhibitor and placed on an Ishikawa cell-covered plate. Erosion of Ishikawa cells occurred after implantation (The bar represents
100 μm). B: Pretreatment with DNMT1 inhibitor significantly decreased the implantation rate of embryos in vitro. The rate of embryo attachment
to Ishikawa cells was 30/71 (42%) and 55/71 (77%) at 48 hours and 72 hours, respectively, for the control group. The rate decreased to 18/71
(25%) and 43/71 (61%) at 48 hours and 72 hours, respectively, in the procainamide treatment group (* P < 0.05). C: The presence of DNMT1
inhibitor did not affect the LIF expression in Ishikawa cells. LIF, leukemia inhibitory factor.
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the genome decreases cell proliferation [15] and the
aborted villous has less cell proliferation and more cell
apoptosis than normal villous [34], insufficient DNA
methylation may influence cell proliferation, migration
and invasion, thus affecting embryonic implantation and
post-implantation development [35].
Implantation is the first and crucial step in governing
reproductive outcomes [36]. Fundamental to this process
are dynamic and precisely ordered molecular and cellular
events, driven by the combination of embryo and host-
receptive-endometrium to facilitate the establishment of
the maternal-fetal interface. Regulation of DNA methyla-
tion plays an important role in this process [35]. In our
in vitro experiment of embryo implantation, the reduc-
tion of the implantation rate may also be caused by
abnormal trophoblastic cell proliferation, migration and
invasion. In addition, the expression of LIF by Ishikawa
cells in the presence of a DNA methylation inhibitor did
not significantly change, testifying to the acceptance of
our embryonic adhesion/implantation model. LIF is one
of the crucial cytokines in the endometrium or at the
maternal-fetal interface [37]. The steady expression of
LIF in the presence of a DNA methylation inhibitor sug-
gests that the disturbance of maintenance methylation
may not influence the endometrial receptivity for
embryos.
The findings of our mouse experiment confirm that dis-
turbance of maintenance DNA methylation plays an
important role in the pathogenesis of EPL. Female mice
that received a uterine injection of a DNA methylation
inhibitor presented typical symptoms of EPL with low
implantation and pregnancy rates, and the embryos in the
treated uterine horn showed global DNA demethylation.
The number of fetuses in the treated uterine horn was less
than the control horn, and the aborted fetuses and placen-
tas in the treated horn had incomplete development of
organs and obscured tissue structures. It has been shown
that knockdown of DNMT1 results in decreased cell viabi-
lity [38]. Further research indicated that DNMT1 had an
intimate relationship with DNA replication and the cell
cycle, since inhibition of DNA methyltransferase interferes
with DNA replication, and DNMT1 depletion triggers
intra-S-phase cell cycle arrest [39]. In the realm of organ-
ism development, DNA methylation also has long-term
effects on the development of the fetus and placenta. Non-
specific demethylation reagents have been found to cause
growth retardation, malformation, fetal lethality and
abnormal tissue structure in the placenta [40]. Thus, we
speculated that the poor formation of the embryonic
organs and tissues in our study might be induced by the
demethylation of the promoters of important developmen-
tal genes, thereby resulting in poor conditions for preg-
nancy. However, a thorough study of the mechanisms
underlying the effect of DNA demethylation on early preg-
nancy loss is needed.
Conclusions
In summary, defects in DNA methylation maintenance
were demonstrated in the villous of human EPL tissues.
Inhibition of DNA methylation maintenance led to a
decreased implantation rate of embryos, increased fetal
absorption, and poor fetal and placental development.
These observations suggest that the embryonic defect in
DNA methylation maintenance may be associated with
abnormal embryonic implantation and development.
Our findings provide new insights into the etiology of
unexplained EPL. However, further experiments are
needed to clarify changes in gene expression and methy-
lation states of genes under the DNA methylation main-
tenance defect in EPL pathogenesis.
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